Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8652 |
High Similarity |
NPD7472 |
Approved |
0.8652 |
High Similarity |
NPD7074 |
Phase 3 |
0.8634 |
High Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.8611 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8603 |
High Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8596 |
High Similarity |
NPD7054 |
Approved |
0.8564 |
High Similarity |
NPD8313 |
Approved |
0.8564 |
High Similarity |
NPD8312 |
Approved |
0.8555 |
High Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8508 |
High Similarity |
NPD7808 |
Phase 3 |
0.8453 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8436 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8398 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8333 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8324 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8324 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8324 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8287 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8265 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.8245 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.8192 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8156 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8132 |
Intermediate Similarity |
NPD7228 |
Approved |
0.8111 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8087 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8077 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8068 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8023 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8023 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7923 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7921 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7921 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.791 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.791 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7901 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7861 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7845 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7833 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.779 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.779 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7789 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7766 |
Intermediate Similarity |
NPD7240 |
Approved |
0.776 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7742 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.774 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7739 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7735 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7717 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.77 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.77 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.768 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.768 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7676 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7672 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7667 |
Intermediate Similarity |
NPD37 |
Approved |
0.7654 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.765 |
Intermediate Similarity |
NPD7698 |
Approved |
0.765 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.765 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7637 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7637 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7637 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7624 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7614 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7611 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7598 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7598 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7588 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7588 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7588 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7588 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7588 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7588 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7588 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7586 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7584 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7528 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7487 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7487 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7429 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7426 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7406 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.7391 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7389 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7377 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7371 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7371 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7363 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7353 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7353 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7345 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7337 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7337 |
Intermediate Similarity |
NPD6535 |
Approved |
0.733 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7318 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7318 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7318 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7296 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7293 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7278 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7278 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7278 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7278 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7273 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7268 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7213 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7211 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7207 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7184 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7182 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7182 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7182 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7159 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7121 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.712 |
Intermediate Similarity |
NPD3226 |
Approved |
0.712 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7119 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7119 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7114 |
Intermediate Similarity |
NPD6212 |
Phase 3 |
0.7114 |
Intermediate Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.7114 |
Intermediate Similarity |
NPD6213 |
Phase 3 |
0.7105 |
Intermediate Similarity |
NPD1247 |
Approved |
0.709 |
Intermediate Similarity |
NPD919 |
Approved |
0.7088 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7086 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7073 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7062 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7056 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7029 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7029 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7029 |
Intermediate Similarity |
NPD943 |
Approved |
0.7022 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7022 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7022 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7022 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7022 |
Intermediate Similarity |
NPD5404 |
Approved |
0.702 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7016 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.701 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.6989 |
Remote Similarity |
NPD447 |
Suspended |
0.6979 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6965 |
Remote Similarity |
NPD4287 |
Approved |
0.6961 |
Remote Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.6952 |
Remote Similarity |
NPD7584 |
Approved |
0.6941 |
Remote Similarity |
NPD5619 |
Clinical (unspecified phase) |
0.6936 |
Remote Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.6932 |
Remote Similarity |
NPD1240 |
Approved |
0.6923 |
Remote Similarity |
NPD8058 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD8059 |
Phase 3 |
0.6919 |
Remote Similarity |
NPD7549 |
Discontinued |
0.6914 |
Remote Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.6905 |
Remote Similarity |
NPD7211 |
Clinical (unspecified phase) |
0.6897 |
Remote Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.6891 |
Remote Similarity |
NPD5711 |
Approved |
0.6891 |
Remote Similarity |
NPD5710 |
Approved |
0.6889 |
Remote Similarity |
NPD2346 |
Discontinued |
0.6884 |
Remote Similarity |
NPD7930 |
Approved |
0.6872 |
Remote Similarity |
NPD651 |
Clinical (unspecified phase) |
0.6868 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6868 |
Remote Similarity |
NPD8166 |
Discontinued |
0.6868 |
Remote Similarity |
NPD7003 |
Approved |
0.6854 |
Remote Similarity |
NPD1607 |
Approved |
0.6842 |
Remote Similarity |
NPD5006 |
Approved |
0.6842 |
Remote Similarity |
NPD5005 |
Approved |
0.6842 |
Remote Similarity |
NPD5353 |
Approved |
0.684 |
Remote Similarity |
NPD7585 |
Approved |
0.6837 |
Remote Similarity |
NPD7177 |
Discontinued |
0.6828 |
Remote Similarity |
NPD920 |
Approved |
0.6818 |
Remote Similarity |
NPD5953 |
Discontinued |
0.6811 |
Remote Similarity |
NPD642 |
Clinical (unspecified phase) |
0.6802 |
Remote Similarity |
NPD7286 |
Phase 2 |
0.6792 |
Remote Similarity |
NPD7583 |
Approved |
0.6778 |
Remote Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.6769 |
Remote Similarity |
NPD5242 |
Approved |
0.6761 |
Remote Similarity |
NPD3027 |
Phase 3 |
0.674 |
Remote Similarity |
NPD6099 |
Approved |
0.674 |
Remote Similarity |
NPD6100 |
Approved |
0.6731 |
Remote Similarity |
NPD4420 |
Approved |
0.6723 |
Remote Similarity |
NPD3764 |
Approved |
0.6722 |
Remote Similarity |
NPD7097 |
Phase 1 |
0.6721 |
Remote Similarity |
NPD2800 |
Approved |
0.6721 |
Remote Similarity |
NPD1243 |
Approved |
0.6705 |
Remote Similarity |
NPD6832 |
Phase 2 |
0.6705 |
Remote Similarity |
NPD4908 |
Phase 1 |
0.6703 |
Remote Similarity |
NPD2344 |
Approved |
0.6703 |
Remote Similarity |
NPD643 |
Clinical (unspecified phase) |
0.6699 |
Remote Similarity |
NPD8285 |
Discontinued |
0.6697 |
Remote Similarity |
NPD7907 |
Approved |
0.6685 |
Remote Similarity |
NPD2799 |
Discontinued |
0.6685 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6684 |
Remote Similarity |
NPD6273 |
Approved |
0.6683 |
Remote Similarity |
NPD8054 |
Approved |
0.6683 |
Remote Similarity |
NPD8053 |
Approved |
0.6681 |
Remote Similarity |
NPD8152 |
Approved |
0.6681 |
Remote Similarity |
NPD8153 |
Approved |
0.6667 |
Remote Similarity |
NPD6841 |
Approved |
0.6667
|
Remote Similarity |
NPD4288 |
Approved |